Alberta Investment Management Corp Abbott Laboratories Transaction History

Alberta Investment Management Corp

$7.8 Billion
Q2 2025

A detailed history of Alberta Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Alberta Investment Management Corp holds 22,800 shares of ABT stock, worth $3.07 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

22,800

Previous 124,749 81.72%

Holding current value

$3.07 Million

Previous $16.5 Million 81.26%

% of portfolio

0.04%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$123.95 - $138.08 $12.6 Million - $14.1 Million	-101,949 Reduced 81.72%	22,800 $3.1 Million
Q1 2025 May 08, 2025	SELL	$111.1 - $140.22 $1.65 Million - $2.09 Million	-14,886 Reduced 10.66%	124,749 $16.5 Million
Q4 2024 Jan 31, 2025	BUY	$111.93 - $119.39 $9 Million - $9.6 Million	80,435 Added 135.87%	139,635 $15.8 Million
Q3 2024 Nov 05, 2024	BUY	$100.07 - $118.13 $2.64 Million - $3.12 Million	26,400 Added 80.49%	59,200 $6.75 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $1.88 Million - $2.1 Million	-18,700 Reduced 36.31%	32,800 $3.41 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $11.1 Million - $13.6 Million	-123,068 Reduced 70.5%	51,500 $5.67 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $2.02 Million - $2.42 Million	-21,122 Reduced 10.79%	174,568 $16.9 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $12.8 Million - $14.3 Million	127,338 Added 186.3%	195,690 $21.3 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $9.29 Million - $10.9 Million	-95,915 Reduced 58.39%	68,352 $6.92 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $230,330 - $270,212	-2,423 Reduced 1.45%	164,267 $18 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $164,492 - $190,451	-1,700 Reduced 1.01%	166,690 $16.1 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $883,926 - $1.07 Million	8,660 Added 5.42%	168,390 $18.3 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $14 Million - $17.1 Million	123,130 Added 336.42%	159,730 $18.9 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $5.11 Million - $5.65 Million	-43,789 Reduced 54.47%	36,600 $4.32 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.27 Million - $1.49 Million	11,989 Added 17.53%	80,389 $9.32 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $1.56 Million - $1.83 Million	-14,300 Reduced 17.29%	68,400 $8.2 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.42 Million - $1.54 Million	13,500 Added 19.51%	82,700 $9.06 Million
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $45,820 - $55,645	500 Added 0.73%	69,200 $7.53 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $1.83 Million - $2.34 Million	23,900 Added 53.35%	68,700 $6.28 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $2.17 Million - $3.18 Million	34,600 Added 339.22%	44,800 $3.54 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $4.71 Million - $5.24 Million	-60,000 Reduced 85.47%	10,200 $886,000
Q3 2019 Oct 23, 2019	BUY	$81.84 - $88.74 $5.75 Million - $6.23 Million	70,200 New	70,200 $5.87 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Abbott Laboratories Transaction History